Transglutaminase-2 of pancreatic cancer cells assembles a CXCL12-keratin 19-coat that mediates the resistance to immunotherapy
Wang, Z.; Li, J.; Gao, Y.; Janowitz, T.; Fearon, D.
Show abstract
How pancreatic ductal adenocarcinoma (PDA) cells stimulate CXCR4 to exclude T cells and resist T cell checkpoint inhibitors is not known. Here, we find that CXCL12, the ligand for CXCR4 that is produced by the cancer-associated fibroblast, "coats" human PDA and colorectal cancer cells as covalent heterodimers with keratin 19 (KRT19). Modeling the formation of the heterodimer with three proteins shows that KRT19 binds CXCL12 and transglutaminase-2 (TGM2), and that TGM2 converts the reversible KRT19-CXCL12 complex into a covalent heterodimer. We validate this model by showing that cancer cells in mouse PDA tumors must express KRT19 and TGM2 to become coated with CXCL12, exclude T cells, and resist immunotherapy with anti-PD-1 antibody. Thus, PDA cells have a cell-autonomous means by which they capture CXCL12 to mediate immune suppression, which is potentially amenable to therapy. One Sentence SummaryCancer cells in pancreatic ductal adenocarcinoma use transglutaminase-2 to assemble a coating comprised of covalent CXCL12-keratin 19 heterodimers that excludes T cells and mediates resistance to inhibition of the PD-1 T cell checkpoint.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A reservoir of stem-like CD8 T cells in the tumor-draining lymph node maintains the ongoing anti-tumor immune response 96%
- Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal anti-tumor immunity 96%
- Cellular selectivity of STING stimulation determines priming of tumor-specific T cell responses 95%
Similar papers in this journal
- Therapeutic KRASG12C inhibition drives effective interferon-mediated anti-tumour immunity in immunogenic lung cancers 96%
- Aberrant cell state plasticity mediated by developmental reprogramming precedescolorectal cancer initiation 95%
- When killers become thieves: trogocytosed PD-1 inhibits NK cells in cancer 95%
Similar papers in this journal
- Inflammatory cytokines mediate the induction of and awakening from metastatic dormancy 96%
- An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade 96%
- Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment 96%
Similar papers in this journal
- Interplay between Desmoglein2 and hypoxia controls metastasis in breast cancer 95%
- T Lymphocyte-Specific Deletion of SHP1 and SHP2 Promotes Activation-Induced Cell Death of CD4+ T Cells and Impairs Antitumor Response 95%
- Lamin B Receptor Upregulation in Metastatic Melanoma Causes Cholesterol-Mediated Nuclear Envelope Fragility 94%
Similar papers in this journal
- VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis 95%
- Tissue-resident NK cells support survival in pancreatic cancer through promotion of cDC1-CD8T activity 95%
- VPS9D1-AS1 overexpression amplifies intratumoral TGF-β signaling and promotes tumor cell escape from CD8+ T cell killing in colorectal cancer 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.